Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.
about
Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nuclear-targeting TAT-PEG-Asp8 ...... e drug-resistant colon cancer.
@en
Nuclear-targeting TAT-PEG-Asp8 ...... e drug-resistant colon cancer.
@nl
type
label
Nuclear-targeting TAT-PEG-Asp8 ...... e drug-resistant colon cancer.
@en
Nuclear-targeting TAT-PEG-Asp8 ...... e drug-resistant colon cancer.
@nl
prefLabel
Nuclear-targeting TAT-PEG-Asp8 ...... e drug-resistant colon cancer.
@en
Nuclear-targeting TAT-PEG-Asp8 ...... e drug-resistant colon cancer.
@nl
P2093
P2860
P356
P1476
Nuclear-targeting TAT-PEG-Asp8 ...... e drug-resistant colon cancer.
@en
P2093
Hui-Yuan Wang
Meng Zhang
Peng-Fei Zhao
Ting-Ting Lin
Wen-Yuan Zhang
Yi-Si Tang
Yong Xiong
Yuan-Er Zeng
Zhen-Zhen Pan
P2860
P2888
P304
P356
10.1038/APS.2016.48
P577
2016-06-13T00:00:00Z
P6179
1000059343